Xuqin Yang
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial(2020)1,207 cited
- → Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults(2021)828 cited
- → Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes(2020)803 cited
- → Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial(2021)40 cited
- → Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial(2022)21 cited
- → Evaluation of the correlations between patient-derived xenograft (PDX) model-based mouse trials and cancer patient-based clinical trials.(2017)8 cited
- → Preclinical evaluation of a two-dose vaccination schedule of recombinantHansenula Polymorphahepatitis B vaccine in animals(2013)3 cited
- → Abstract 1210: A patient derived xenograft tumor model platform for “mouse trials”(2014)
- → 154 Drug response database with PDX tumor models in biomarker-driven multi-drug multi-arm clinical trial settings(2014)
- → Abstract 3222: Biomarker discovery through bioinformatic analysis of genomic profiles of PDX models with different responses to cancer therapies(2015)